Literature DB >> 24303897

Subsets of human natural killer cells and their regulatory effects.

Binqing Fu1, Zhigang Tian, Haiming Wei.   

Abstract

Human natural killer (NK) cells have distinct functions as NK(tolerant) , NK(cytotoxic) and NK(regulatory) cells and can be divided into different subsets based on the relative expression of the surface markers CD27 and CD11b. CD27⁺ NK cells, which are abundant cytokine producers, are numerically in the minority in human peripheral blood but constitute the large population of NK cells in cord blood, spleen, tonsil and decidua tissues. Recent data suggest that these NK cells may have immunoregulatory properties under certain conditions. In this review, we will focus on these new NK cell subsets and discuss how regulatory NK cells may serve as rheostats or sentinels in controlling inflammation and maintaining immune homeostasis in various organs.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  cell differentiation; human natural killer cells

Mesh:

Substances:

Year:  2014        PMID: 24303897      PMCID: PMC3956422          DOI: 10.1111/imm.12224

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  79 in total

1.  Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells.

Authors:  Hiroshi Chinen; Katsuyoshi Matsuoka; Toshiro Sato; Nobuhiko Kamada; Susumu Okamoto; Tadakazu Hisamatsu; Taku Kobayashi; Hirotoshi Hasegawa; Akira Sugita; Fukunori Kinjo; Jiro Fujita; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682

Review 2.  Natural killer cells in human autoimmunity.

Authors:  Malin Flodström-Tullberg; Yenan T Bryceson; Fu-Dong Shi; Petter Höglund; Hans-Gustaf Ljunggren
Journal:  Curr Opin Immunol       Date:  2009-11-04       Impact factor: 7.486

3.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

Authors:  Todd A Fehniger; Megan A Cooper; Gerard J Nuovo; Marina Cella; Fabio Facchetti; Marco Colonna; Michael A Caligiuri
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

4.  A role for Blimp1 in the transcriptional network controlling natural killer cell maturation.

Authors:  Axel Kallies; Sebastian Carotta; Nicholas D Huntington; Nicholas J Bernard; David M Tarlinton; Mark J Smyth; Stephen L Nutt
Journal:  Blood       Date:  2010-12-03       Impact factor: 22.113

Review 5.  Developmental pathways that generate natural-killer-cell diversity in mice and humans.

Authors:  Nicholas D Huntington; Christian A J Vosshenrich; James P Di Santo
Journal:  Nat Rev Immunol       Date:  2007-09       Impact factor: 53.106

6.  Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.

Authors:  Bibiana Bielekova; Thomas Howard; Amy N Packer; Nancy Richert; Gregg Blevins; Joan Ohayon; Thomas A Waldmann; Henry F McFarland; Roland Martin
Journal:  Arch Neurol       Date:  2009-04

7.  CD27 defines phenotypically and functionally different human NK cell subsets.

Authors:  Mireille T M Vossen; Mourad Matmati; Kirsten M L Hertoghs; Paul A Baars; Mi-Ran Gent; Georges Leclercq; Jörg Hamann; Taco W Kuijpers; René A W van Lier
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

Review 8.  Organ-specific features of natural killer cells.

Authors:  Fu-Dong Shi; Hans-Gustaf Ljunggren; Antonio La Cava; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2011-09-23       Impact factor: 53.106

9.  Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.

Authors:  Silke Paust; Harvinder S Gill; Bao-Zhong Wang; Michael P Flynn; E Ashley Moseman; Balimkiz Senman; Marian Szczepanik; Amalio Telenti; Philip W Askenase; Richard W Compans; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2010-10-24       Impact factor: 25.606

10.  TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.

Authors:  Cheng Sun; Binqing Fu; Yufeng Gao; Xiaofeng Liao; Rui Sun; Zhigang Tian; Haiming Wei
Journal:  PLoS Pathog       Date:  2012-03-15       Impact factor: 6.823

View more
  63 in total

Review 1.  Immune Mechanisms and Pathways Targeted in Type 1 Diabetes.

Authors:  Laura M Jacobsen; Brittney N Newby; Daniel J Perry; Amanda L Posgai; Michael J Haller; Todd M Brusko
Journal:  Curr Diab Rep       Date:  2018-08-30       Impact factor: 4.810

Review 2.  TH17 cells in human recurrent pregnancy loss and pre-eclampsia.

Authors:  Binqing Fu; Zhigang Tian; Haiming Wei
Journal:  Cell Mol Immunol       Date:  2014-07-14       Impact factor: 11.530

3.  CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation.

Authors:  Laura Hertwig; Isabell Hamann; Silvina Romero-Suarez; Jason M Millward; Rebekka Pietrek; Coralie Chanvillard; Hanna Stuis; Karolin Pollok; Richard M Ransohoff; Astrid E Cardona; Carmen Infante-Duarte
Journal:  Eur J Immunol       Date:  2016-07-14       Impact factor: 5.532

Review 4.  Natural killer cells in liver diseases.

Authors:  Meijuan Zheng; Haoyu Sun; Zhigang Tian
Journal:  Front Med       Date:  2018-04-19       Impact factor: 4.592

5.  Depletion but Activation of CD56dimCD16+ NK Cells in Acute Infection with Severe Fever with Thrombocytopenia Syndrome Virus.

Authors:  Mengmeng Li; Yan Xiong; Mingyue Li; Wenjing Zhang; Jia Liu; Yanfang Zhang; Shue Xiong; Congcong Zou; Boyun Liang; Mengji Lu; Dongliang Yang; Cheng Peng; Xin Zheng
Journal:  Virol Sin       Date:  2020-05-19       Impact factor: 4.327

6.  Practical NK cell phenotyping and variability in healthy adults.

Authors:  Laura S Angelo; Pinaki P Banerjee; Linda Monaco-Shawver; Joshua B Rosen; George Makedonas; Lisa R Forbes; Emily M Mace; Jordan S Orange
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

7.  Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control.

Authors:  Christopher W Pohlmeyer; Veronica D Gonzalez; Alivelu Irrinki; Ricardo N Ramirez; Li Li; Andrew Mulato; Jeffrey P Murry; Aaron Arvey; Rebecca Hoh; Steven G Deeks; George Kukolj; Tomas Cihlar; Stefan Pflanz; Garry P Nolan; Gundula Min-Oo
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

8.  The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells.

Authors:  Sara E Martin del Campo; Kala M Levine; Bethany L Mundy-Bosse; Valerie P Grignol; Ene T Fairchild; Amanda R Campbell; Prashant Trikha; Thomas A Mace; Bonnie K Paul; Alena Cristina Jaime-Ramirez; Joseph Markowitz; Sri Vidya Kondadasula; Kristan D Guenterberg; Susan McClory; Volodymyr I Karpa; Xueliang Pan; Thomas E Olencki; J Paul Monk; Amir Mortazavi; Susheela Tridandapani; Gregory B Lesinski; John C Byrd; Michael A Caligiuri; Manisha H Shah; William E Carson
Journal:  J Immunol       Date:  2015-08-03       Impact factor: 5.422

Review 9.  Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy.

Authors:  Yuan Hu; Zhi-Gang Tian; Cai Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-09-07       Impact factor: 6.150

10.  NLRP3 and Potassium Efflux Drive Rapid IL-1β Release from Primary Human Monocytes during Toxoplasma gondii Infection.

Authors:  Lanny Gov; Christine A Schneider; Tatiane S Lima; William Pandori; Melissa B Lodoen
Journal:  J Immunol       Date:  2017-09-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.